Sun Young Rha

Researcher Next ID · RN-005792

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Gastric Cancer Management and Outcomes

Colorectal Cancer Treatments and Studies

HER2/EGFR in Cancer Research

Renal cell carcinoma treatment

Cancer Immunotherapy and Biomarkers

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
The Lancet Oncology · 2023 · https://doi.org/10.1016/s1470-2045(23)00515-6
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2035716
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(15)01283-0
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(12)70559-4
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.36.2236

No projects listed.